Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 101

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 101
---
,000 |     |                              | 0.31 |     |                                                              | 40,000 |
| Total                                                          |     |                                 | 4,960,000 |     | $                            | 0.31 |     |                                                              | 40,000 |

<div align='center'>62

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>

The following table sets forth certain information regarding the ownership of Common Stock as of February 14, 2025 by of (i) each of our current directors, (ii) each of the Named Executive Officers, (iii) all of our current directors and executive officers as a group, and (iv) each person (or group of affiliated persons) known to us who owns more than 5% of our outstanding Common Stock.

The beneficial ownership of our Common Stock is determined in accordance with the rules of the SEC. Under these rules, a person is deemed to be a beneficial owner of a security if that person directly or indirectly has or shares voting power, which includes the power to vote or to direct the voting of the security, or investment power, which includes the power to dispose of or to direct the disposition of the security. The person is also deemed to be a beneficial owner of any security of which that person has a right to acquire beneficial ownership within 60 days. Under the SEC rules, more than one person may be deemed to be a beneficial owner of the same securities, and a person may be deemed to be a beneficial owner of securities as to which he or she may not have any pecuniary interest.

The percentage of shares of Common Stock beneficially owned is based on 60,729,100 shares of Common Stock outstanding as of February 14, 2025.

Unless otherwise indicated below each person has sole voting and investment power with respect to the shares beneficially owned and the address for each beneficial owner listed in the table below is c/o Revium Rx., 10 HaMenofim Street, Herzliya, Israel.

|                                       |     | Amount and 
 nature of  |           |    |     | Percentage of          
 Shares of Common Stock 
 beneficially owned     |      |   |     |          |      |   |
| Name of Beneficial Owner              |     | beneficial 
 ownership  |           |    |     | Before                 
 offering               |      |   |     | After    
 offering |      |   |
| Directors and Executive Officers      |     |            |           |    |